Technology Knowledge Optimization in Type 1 Diabetes (TeKnO T1D): Parents
Key facts
- Who runs it
- Children's Hospital of Philadelphia
- Where
- Philadelphia, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- 15 Aug 2025
- Expected to end
- 31 Jul 2027
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- TeKnO T1D: Parents
- Record updated
- 9 October 2025
- Why it stopped
- Investigator left the institution and is relinquishing the award supporting this study. The study will not launch.
Who can take part
- Age
- 8 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (8)Hide the full registry criteria
Who can take part
- child 8-12 years of age with a diagnosis of T1D ≥ 6 months
- currently using insulin pump( IP) and CGM ≥ 1 month [including Hybrid Closed Loop (HCL) systems]
- participation of primary diabetes caregiver
- English fluency
- mean A1c >7.5% over the past 6 months (Aim 3 only)
Who cannot take part
- major illnesses other than T1D in the child
- significant cognitive limitations or major psychiatric disorders in the child or parent
- the use of medications other than insulin to control blood glucose levels
Where in United States
- Childrens Hospital of PhiladelphiaPhiladelphia, United States
About the trial
What the trial wants to find out
This study aims to identify the unmet psychoeducational needs of parents of children 8-12 years of age using insulin pump and CGM for pediatric T1D management and to leverage that information to develop an innovative app-based psychoeducational intervention to optimize use of these technologies and improve T1D outcomes.
The 3 groups in the trial
- Arm 1: Semi-structured InterviewsNo study treatment, for comparison
Arm 1 will be conducted from months 0-15 and will use interviews to better understand existing challenges in diabetes technology educational practices. It is not a clinical trial, but is a crucial part of what builds to the clinical trial.
- Arm 2: Designing an App Delivered CurriculumTreatment being tested
Arm 2 will be conducted from months 10-33 and will use information learned in arm 1 to develop and beta test an educational curriculum. Arm 2 also is not a clinical trial, but is a crucial part of what builds to the clinical trial.
Treatment: TeKnO T1D: Parents
- Arm 3: TeKnO T1D: Parents Pilot StudyExisting treatment, for comparison
Arm 3 will be conducted from months 30-60 and involves a pilot and feasibility study of the newly developed educational curriculum. This is the clinical trial.
Treatment: TeKnO T1D: Parents
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 9 October 2025